Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

OXCARBAZEPINE Drug Profile

« Back to Dashboard

Which patents cover Oxcarbazepine, and what generic Oxcarbazepine alternatives are available?

Oxcarbazepine is a drug marketed by Taro, Glenmark Generics, Ani Pharms Inc, Sun Pharm Inds Ltd, Jubilant Cadista, Apotex Inc, Amneal Pharms, Breckenridge Pharm, West-ward Pharms Int, and Sun Pharm Inds. and is included in eleven NDAs.

The generic ingredient in OXCARBAZEPINE is oxcarbazepine. There are eighteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the oxcarbazepine profile page.

Summary for Tradename: OXCARBAZEPINE

Patents:0
Applicants:10
NDAs:11
Suppliers / Packagers: see list24
Bulk Api Vendors: see list59
Clinical Trials: see list14
Patent Applications: see list2,673
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXCARBAZEPINE at DailyMed

Pharmacology for Tradename: OXCARBAZEPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL077801-001Nov 15, 2007ABRXNoNo► Subscribe► Subscribe
Breckenridge Pharm
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL078069-001Jan 11, 2008ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL077794-003Oct 9, 2007ABRXNoNo► Subscribe► Subscribe
Ani Pharms Inc
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL078005-001Dec 11, 2007ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL077802-001Oct 9, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot